Fubotv earnings beat by $0.10, revenue topped estimates
LONDON - BioPharma Credit PLC (LSE: BPCR), a specialist investor in life sciences debt, has declared an interim dividend for the quarter ending December 31, 2024. Shareholders will receive a distribution of 2.892309 cents per share, which includes an ordinary dividend of 1.75 cents and a special dividend of 1.142309 cents. The payment is scheduled for February 28, 2025, to shareholders recorded as of January 31, 2025.
The ex-dividend date is set for January 30, 2025. With this distribution, the total dividends for the 2024 calendar year to date will reach 10.18 cents per share. BioPharma Credit aims to maintain a 7-cent base annual dividend per ordinary share.
This interim dividend will be entirely designated as an interest distribution, which has implications for UK tax treatment. Shareholders will be considered as having received interest income, and the company will benefit from a reduction in corporation tax payable.
Dividends will be paid in US dollars by default, but shareholders have the option to receive payments in sterling (GBP). To select this option, shareholders must submit a Dividend Currency Election Form to Link Group by January 31, 2025, also known as the Election Date. The necessary forms and further details will be provided on the company's website and through the CREST system for registered shareholders.
The announcement is based on a press release statement issued by BioPharma Credit PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.